CNE100005204
CNE100005204
SHENZHEN YHLO BIOTECH CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.98B EUR | 5.01B EUR | 8.35B EUR |
Enterprise Value | 6.25B EUR | 5.3B EUR | 8.7B EUR |
Valuation Multiples | |||
Trailing P/E | 95.09x | 101.79x | 1,170.03x |
Forward P/E | -- | -- | -- |
Price to Sales | 3.16x | 2.78x | 4.83x |
Price to Book | 2.17x | 1.82x | 3.08x |
EV/Revenue | 3.31x | 2.94x | 5.03x |
EV/EBITDA | 12.16x | 30.9x | 56.55x |
Price to FCF (P/FCF) | -- | 65.47x | 558.13x |
EV/FCF | -- | 69.32x | 580.99x |
FCF Yield | -1.91% | 1.53% | 0.18% |